Stereotactic body radiotherapy, a radiation therapy procedure pioneered at the University of Pittsburgh Cancer Institute that precisely delivers a large dose of radiation to tumors, may effectively control and treat head and neck cancers when combined with the chemotherapy Cetuximab, according to researchers.